JP2021519261A5 - - Google Patents
Info
- Publication number
- JP2021519261A5 JP2021519261A5 JP2020551257A JP2020551257A JP2021519261A5 JP 2021519261 A5 JP2021519261 A5 JP 2021519261A5 JP 2020551257 A JP2020551257 A JP 2020551257A JP 2020551257 A JP2020551257 A JP 2020551257A JP 2021519261 A5 JP2021519261 A5 JP 2021519261A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- seq
- composition
- inhibitor
- composition according
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862645847P | 2018-03-21 | 2018-03-21 | |
| US62/645,847 | 2018-03-21 | ||
| US201862782480P | 2018-12-20 | 2018-12-20 | |
| US62/782,480 | 2018-12-20 | ||
| PCT/US2019/023461 WO2019183415A1 (en) | 2018-03-21 | 2019-03-21 | Compositions and methods for cellular reprogramming |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021519261A JP2021519261A (ja) | 2021-08-10 |
| JPWO2019183415A5 JPWO2019183415A5 (https=) | 2022-03-30 |
| JP2021519261A5 true JP2021519261A5 (https=) | 2022-03-30 |
Family
ID=67988091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551257A Pending JP2021519261A (ja) | 2018-03-21 | 2019-03-21 | 細胞リプログラミングのための組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11512290B2 (https=) |
| EP (1) | EP3768283A4 (https=) |
| JP (1) | JP2021519261A (https=) |
| CA (1) | CA3094658A1 (https=) |
| WO (1) | WO2019183415A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024316608A1 (en) * | 2023-08-02 | 2026-03-05 | The Children's Medical Center Corporation | Targeting tlr3 for treatment of hematopoietic stem cell proliferation-associated diseases or disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2804791C (en) * | 2010-07-08 | 2019-07-30 | Duke University | Direct reprogramming of cells to cardiac myocyte fate |
| WO2013109763A2 (en) * | 2012-01-17 | 2013-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Activation of innate immunity for nuclear reprogramming of somatic cells |
| US10130637B2 (en) | 2012-11-02 | 2018-11-20 | Duke University | Inhibition of histone methyltransferase for cardiac reprogramming |
| WO2014169049A1 (en) * | 2013-04-09 | 2014-10-16 | Duke University | 2' fluoro-modified rnas as immunostimulators |
| WO2016022992A1 (en) * | 2014-08-07 | 2016-02-11 | Duke University | Compositions and methods for the reprogramming of cells into cardiomyocytes |
| EP3270984A4 (en) * | 2015-03-16 | 2019-04-17 | Duncan Ross | TREATMENT METHOD WITH MEMBRANE-INCLUDED VESICLE |
| CN110709515A (zh) * | 2017-04-03 | 2020-01-17 | 杜克大学 | 用于差异性诱导细胞死亡和干扰素表达的组合物和方法 |
-
2019
- 2019-03-21 US US16/982,964 patent/US11512290B2/en active Active
- 2019-03-21 EP EP19770961.1A patent/EP3768283A4/en not_active Withdrawn
- 2019-03-21 JP JP2020551257A patent/JP2021519261A/ja active Pending
- 2019-03-21 CA CA3094658A patent/CA3094658A1/en active Pending
- 2019-03-21 WO PCT/US2019/023461 patent/WO2019183415A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5898843B2 (ja) | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 | |
| Orenes-Piñero et al. | Role of microRNAs in cardiac remodelling: new insights and future perspectives | |
| McDermott et al. | The therapeutic potential of microRNAs: disease modulators and drug targets | |
| Wang et al. | Role of microRNAs in cardiac hypertrophy and heart failure | |
| Piccoli et al. | Non-coding RNAs as modulators of the cardiac fibroblast phenotype | |
| US8642751B2 (en) | MicroRNA inhibitors comprising locked nucleotides | |
| MX2014015641A (es) | Inhibidores de la familia mir-15 de micro-arns. | |
| JP2017528441A5 (https=) | ||
| Papageorgiou et al. | Prognostic role of miRNAs in coronary artery disease | |
| Mirzadeh Azad et al. | Small molecules with big impacts on cardiovascular diseases | |
| CN105861551A (zh) | 联合表达microRNAs抑制乳腺癌细胞增殖的载体及其构建方法和应用 | |
| US9220724B2 (en) | MicroRNA-based approach to treating malignant pleural mesothelioma | |
| JP2021519261A5 (https=) | ||
| US20230304006A1 (en) | Anti-seed pnas and microrna inhibition | |
| Profumo et al. | Targeting microRNAs to withstand cancer metastasis | |
| US20230129651A1 (en) | Hairpin structure nucleic acid molecules capable of modulating target gene expression and uses thereof | |
| JPWO2019183415A5 (https=) | ||
| CN104031987B (zh) | miRNA在心肌纤维化疾病治疗中的应用 | |
| KR102897439B1 (ko) | 타겟 유전자 발현을 조절할 수 있는 핵산 분자 및 이의 용도 | |
| Formosa et al. | Salivary miRNAome profiling uncovers epithelial and proliferative miRNAs with differential expression across dentition stages | |
| CN103316347A (zh) | 微小核苷酸及其拮抗剂或模拟剂在制备抗心肌损伤及纤维化药物中的应用 | |
| Nath et al. | From life to death: microRNAs in the fine tuning of the heart |